Eric Cantor Named New Chief Executive of Pharma Lobby PhRMA
Eric Cantor, former GOP House majority leader, will lead PhRMA as its next chief executive.
The lobbying group representing major pharmaceutical companies announced that Eric Cantor will assume the role of CEO. Cantor steps into the position as lawmakers intensify scrutiny over drug pricing. One outlet administration is working to formalize voluntary price-cut agreements with dozens of firms, while Democrats explore linking Medicare negotiations to international price benchmarks.
